2005
DOI: 10.1002/pd.1237
|View full text |Cite
|
Sign up to set email alerts
|

Hydrops fetalis: an unusual prenatal presentation of hereditary congenital lymphedema

Abstract: PCL should be considered in the differential diagnosis of hydrops fetalis. Knowledge of the favorable course, variable clinical presentation, therapy options and genetic basis should contribute to better pregnancy counseling and management.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
44
0
1

Year Published

2006
2006
2024
2024

Publication Types

Select...
7
3

Relationship

2
8

Authors

Journals

citations
Cited by 45 publications
(45 citation statements)
references
References 18 publications
0
44
0
1
Order By: Relevance
“…This is usually present at birth, is bilateral, and affects the feet up to the knees (4,5). Patients sometimes present with prenatal pleural effusion or in utero hydrops (6,7). Nonne-Milroy lymphedema is usually an autosomal dominant disorder, yet de novo mutations are not infrequent (7)(8)(9)(10).…”
Section: Vegf-c/vegfr-3 Signaling Axismentioning
confidence: 99%
“…This is usually present at birth, is bilateral, and affects the feet up to the knees (4,5). Patients sometimes present with prenatal pleural effusion or in utero hydrops (6,7). Nonne-Milroy lymphedema is usually an autosomal dominant disorder, yet de novo mutations are not infrequent (7)(8)(9)(10).…”
Section: Vegf-c/vegfr-3 Signaling Axismentioning
confidence: 99%
“…De novo mutations are possible too. Gene defects within one of three commonly described lymphangiogenic genes can lead to some degree of hydrops fetalis, such as in Milroy disease (MIM 153100, congenital lymphedema, VEGFR3 mutation), hypotrichosis-lymphedema-telangiectasia syndrome (childhood onset lymphedema, SOX18 mutation), and lymphedema-distichiasis (puberty onset lymphedema, FOXC2 mutation) [3,6]. The current case carries a truncating mutation in the forkhead-related transcription factor FOXC2 (MIM 153400) and stresses the fact that a wide intrafamilial variation in the clinical expression of this mutation is possible.…”
Section: Discussionmentioning
confidence: 99%
“…Prenatal findings suggestive of PCL warrant a targeted ultrasound, fetal karyotyping, and serial limited ultrasounds to look for progression of lymphatic dysfunction as evidenced by worsening lymphedema. Spontaneous resolution of PCL associated lymphedema during fetal life has also been reported to occur [21]. Prenatal genetic testing for PCL is not widely available; however, Sanger sequencing as well as deletion/duplication testing for the VEGFR3/FLT4 gene is available.…”
Section: Discussionmentioning
confidence: 99%